|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | ||||
| General and administrative | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Change in fair value—preferred stock tranche obligation | ||||
| Other income (expense), net | ||||
| Interest expense | ||||
| Loss before income taxes | ||||
| Income tax benefit (expense) | ||||
| Loss on early extinguishment of Term Loan | ||||
| Net loss | ||||
| Other comprehensive income (loss): | ||||
| Net unrealized gain (loss) on available-for-sale-investments, net of tax | ||||
| Total comprehensive loss | ||||
| Net loss per share, basic and diluted (in USD per share) | ||||
| Weighted-average number of shares outstanding, basic and diluted (in shares) | ||||
| Net loss per share, basic (in USD per share) | ||||
| Net loss per share, diluted (in USD per share) | ||||
| Weighted-average number of shares outstanding, basic (in shares) | ||||
| Weighted-average number of shares outstanding, diluted (in shares) |
Loading...